CrushSCI.com
114.4Average days
108.5Median days
11Fastest days
229Longest days
2962025 publications

Paper Review Records

All Paper Review Records

24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

13 days

Circulating tumor cells in lobular versus ductal metastatic breast cancer

Authors
Emily M. Dolce; Elizabeth P. Darga; Nicholas C. Henderson; Dafydd G. Thomas; David A. Hanauer; Arul M. Chinnaiyan; Erin F. Cobain; N. Lynn Henry; Costanza Paoletti; Andi K. Cani; Daniel F. HayesShow moreShow less
Affiliations
1. Breast Oncology Section, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA; 2. University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, USA; 3. Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, USA; 4. Department of Pathology and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, USA; 5. Department of Pediatrics and School of Information, University of Michigan, Ann Arbor, USAShow moreShow less
Source PDF DOI Publisher page
75 days

Risk of malignancy after diagnosis of radial sclerosing lesion with associated atypia

Authors
Lorena Beatriz Delgado Casanova; Sagar Dhamne; Erika Resetkova; Mary S. Guirguis; Yimin Geng; Therese Bartholomew Bevers; Isabelle Bedrosian; Lei Huo; Kerollos Nashat WanisShow moreShow less
Affiliations
1. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; 2. Universidad Central del Caribe, Bayamón, USA; 3. Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; 4. Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA; 5. Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, USA; 6. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, USA; 7. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA; 8. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, USA; 9. Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, USAShow moreShow less
Source PDF DOI Publisher page
166 days

GLP-1 receptor agonist–associated weight loss in breast cancer patients receiving concurrent endocrine therapy: a retrospective cohort analysis

Authors
Keri Morgan Cronin; Amy TierstenShow moreShow less
Affiliations
1. Department of Breast Oncology, Mount Sinai Hospital, New York, USAShow moreShow less
Source PDF DOI Publisher page
179 days

Recent trends in race and ethnicity reporting in breast surgery journals

Authors
Omar Font-Torres; Shahenda Khedr; Victoria Ende; Julie Hong; Xiaoyue Ma; Daniella Abramov; Anisa Raidah; Janice Zhang; Angela Colback; Jonaki Debi; Manmeet Malik; Vivian Bea; Lisa Newman; Daithi S. Heffernan; Steven Chao; Tammy JuShow moreShow less
Affiliations
1. Department of General Surgery, New York Presbyterian-Queens, Queens, USA; 2. Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medical College, New York, USA; 3. Department of Breast Surgery, New York Presbyterian-Queens, Queens, USA; 4. Department of Surgery, New York Presbyterian- Brooklyn Methodist, Brooklyn, USA; 5. Department of Surgery, Weill Cornell Medicine, New York, USA; 6. Department of Surgery, Brown University, Providence, USAShow moreShow less
Source PDF DOI Publisher page
59 days

Real-world treatment patterns and clinical outcomes in patients with emerging estrogen receptor 1 (ESR1)-mutated ER+ metastatic breast cancer in the U.S., 2018-2024

Authors
Jane L. Meisel; Clara Chen; Ayush Kris; Meng Ru; Timothy Pham; James RooseShow moreShow less
Affiliations
1. Department of Hematology and Medical Oncology, Emory Winship Cancer Institute, Emory University, Atlanta, USA; 2. AstraZeneca, Gaithersburg, USA; 3. Flatiron Health, New York, USAShow moreShow less
Source PDF DOI Publisher page
103 days

Exploring trop-2-directed ADCs monotherapy and combination therapy in pretreated mTNBC: a real-world study

Authors
Jingze Liu; Linxiaoxiao Ding; Jiayi Wang; Tao Chen; Tianzhu Long; Qian Li; Jie Chai; Herui Yao; Ying Wang; Jianli ZhaoShow moreShow less
Affiliations
1. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China; 2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 3. Thyroid and Breast Surgery Department, Guangzhou Women and Children’s Medical center, Guangzhou Medical University, Guangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.